以患者为中心的整合发药标准:ASCO/NCODA 标准
ASCO与NCODA组建专家组,系统检索至2019年4月的文献并参考NCODA既有标准,制定口服抗肿瘤药及支持治疗药物整合发药的患者中心标准。纳入的系统评价及5项多组分干预研究提示,以肿瘤药师主导、含患者教育与随访监测的干预可改善用药安全、依从性及患者结局。
要点
- 口服抗肿瘤药整合发药应采用以患者为中心的多组分干预模式。
- 肿瘤药师主导、结合患者教育与定期随访监测可改善依从性与安全性。
- 标准覆盖患者关系与教育、依从性、安全性、数据收集与记录等环节。
核心结论
- 系统评价结果与NCODA以患者为中心的标准一致,该标准被采纳为ASCO/NCODA标准的基础。
研究设计与样本
- ASCO组建专家组,系统检索PubMed与Google Scholar至2019年4月的文献,并公开征集意见后定稿。
主要发现
- 纳入一项截至2016年5月的高质量系统评价及5项符合标准的多组分干预原始研究。
- 这些研究多由肿瘤药师主导,并包含患者教育与定期随访监测,显著改善患者质量与安全,并改善依从性等结局。
关键数值与推荐
- 标准涵盖患者关系与教育、依从性、安全性、数据收集、记录及其他领域。
临床怎么用
- 口服抗肿瘤药及支持治疗药物发药应整合多组分干预,由肿瘤药师参与并落实教育与随访监测。
局限性
- 纳入的原始研究数量有限,且多为多组分干预,难以区分单一成分的独立效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide standards for medically integrated dispensing of oral anticancer drugs and supportive care medications. METHODS: An Expert Panel was formed, and a systematic review of the literature on patient-centered best practices for the delivery of oral anticancer and supportive care drugs was performed to April 2019 using PubMed and Google Scholar. Available patient-centered standards, including one previously developed by the National Community Oncology Dispensing Association (NCODA), were considered for endorsement. Public comments were solicited and considered in preparation of the final manuscript. RESULTS: A high-quality systematic review that was current to May 2016 was adopted into the evidence base. Five additional primary studies of multifaceted interventions met the inclusion criteria. These studies generally included a multicomponent intervention, often led by an oncology pharmacist, and also included patient education and regular follow-up and monitoring. These interventions resulted in significant improvements to patient quality and safety and demonstrated improvements in adherence and other patient outcomes. CONCLUSION: The findings of the systematic review were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation, and other areas. NCODA standards were adopted and used as basis for these American Society of Clinical Oncology/NCODA standards. Additional information is available at www.asco.org/mid-standards.
引用
- Dillmon MS, Kennedy EB, Anderson MK, et al. Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. J Clin Oncol. 2019. PMID: 31815576. doi:10.1200/JCO.19.02297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。